Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-012969
Filing Date
2019-08-19
Accepted
2019-08-19 11:50:39
Documents
55
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 781175
2 logo.jpg GRAPHIC 4391
3 ex31-1.htm EX-31.1 20474
4 ex31-2.htm EX-31.2 18276
5 ex32-1.htm EX-32.1 7762
  Complete submission text file 0001493152-19-012969.txt   3600144

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE gcan-20190630.xml EX-101.INS 533271
7 XBRL SCHEMA FILE gcan-20190630.xsd EX-101.SCH 51868
8 XBRL CALCULATION FILE gcan-20190630_cal.xml EX-101.CAL 39605
9 XBRL DEFINITION FILE gcan-20190630_def.xml EX-101.DEF 199802
10 XBRL LABEL FILE gcan-20190630_lab.xml EX-101.LAB 290498
11 XBRL PRESENTATION FILE gcan-20190630_pre.xml EX-101.PRE 241736
Mailing Address 15 WALKER AVE, SUITE 101 BALTIMORE MD 21208
Business Address 15 WALKER AVE, SUITE 101 BALTIMORE MD 21208 (443) 738-4051
Greater Cannabis Company, Inc. (Filer) CIK: 0001695473 (see all company filings)

EIN.: 300842570 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-56027 | Film No.: 191035732
SIC: 2834 Pharmaceutical Preparations